Youling Gong

Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer

You Lü, Jianxin Xue, Tao Deng et al. · Nature Medicine · 2020 · 510 citations

Off-target Effect, Medicine, Immunology +10

Circular RNA F-circEA-2a derived from EML4-ALK fusion gene promotes cell migration and invasion in non-small cell lung cancer

Shuangyan Tan, Dan Sun, Wenchen Pu et al. · Molecular Cancer · 2018 · 147 citations · Full text

Efficacy, safety, and biomarker analysis of ensartinib in crizotinib-resistant, ALK-positive non-small-cell lung cancer: a multicentre, phase 2 trial

Yunpeng Yang, Jianya Zhou, Jianying Zhou et al. · The Lancet Respiratory Medicine · 2019 · 135 citations

Biomarker Analysis, Medicine, Pharmacology +8

Effect of Low-Dose Radiation Therapy on Abscopal Responses to Hypofractionated Radiation Therapy and Anti-PD1 in Mice and Patients With Non-Small Cell Lung Cancer

Limei Yin, Jianxin Xue, Rui Li et al. · International Journal of Radiation Oncology*Biology*Physics · 2020 · 131 citations

Radiation Therapy, Medicine, Hypofractionated Radiation Therapy +8

Planning analysis for locally advanced lung cancer: dosimetric and efficiency comparisons between intensity-modulated radiotherapy (IMRT), single-arc/partial-arc volumetric modulated arc therapy (SA/PA-VMAT)

Xiaoqin Jiang, Tao Li, Yongmei Liu et al. · Radiation Oncology · 2011 · 99 citations · Full text